Shanghai, China

Yushen Guo

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yushen Guo: Innovator in Pharmaceutical Formulations

Introduction

Yushen Guo is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid formulations for PARP inhibitors. His innovative work has the potential to impact the treatment of diseases associated with PARP activity abnormalities.

Latest Patents

Yushen Guo holds a patent for a solid pharmaceutical formulation of PARP inhibitors. The patent describes a solid dispersion powder that includes 5-fluoro-1-(4-fluoro-3-(4-(pyrimidin-2-yl)piperazine-1-carbonyl)benzyl)quinazoline-2,4(1H,3H)-dione and polymers. The formulation specifies that the content of polymers ranges from about 50 wt % to about 80 wt %, with less than 10 wt % of the active ingredient in crystalline form. This invention also outlines a method for preparing the solid dispersion powder and its use in pharmaceutical compositions for treating related diseases.

Career Highlights

Throughout his career, Yushen Guo has worked with several prominent companies in the pharmaceutical industry. Notable among these are Impact Therapeutics, Inc. and Jiangsu Yahong Meditech Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical formulations and innovations.

Collaborations

Yushen Guo has collaborated with several professionals in his field, including Suixiong Cai and Jie Chen. These collaborations have likely enhanced his research and development efforts in pharmaceutical sciences.

Conclusion

Yushen Guo is a distinguished inventor whose work in solid pharmaceutical formulations has the potential to advance treatment options for diseases linked to PARP activity. His contributions to the field are noteworthy and reflect his commitment to innovation in pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…